TWD 40.9
(0.25%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 459.99 Million TWD | -12.97% |
2022 | 528.52 Million TWD | -7.49% |
2021 | 571.31 Million TWD | 32.53% |
2020 | 431.08 Million TWD | -1.1% |
2019 | 435.86 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 117.87 Million TWD | 1.08% |
2024 Q2 | 83.4 Million TWD | -29.24% |
2023 Q4 | 116.61 Million TWD | 7.67% |
2023 FY | 459.99 Million TWD | -12.97% |
2023 Q3 | 108.3 Million TWD | -1.52% |
2023 Q2 | 109.98 Million TWD | -12.08% |
2023 Q1 | 125.09 Million TWD | -6.49% |
2022 FY | 528.52 Million TWD | -7.49% |
2022 Q4 | 133.77 Million TWD | 0.0% |
2021 FY | 571.31 Million TWD | 32.53% |
2020 FY | 431.08 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Allied Biotech Corporation | 720.43 Million TWD | 36.15% |
GeneFerm Biotechnology Co., Ltd. | 793.77 Million TWD | 42.05% |
Easywell Biomedicals, Inc. | 271.62 Million TWD | -69.347% |
TTY Biopharm Company Limited | 5.5 Billion TWD | 91.645% |
Synmosa Biopharma Corporation | 5.14 Billion TWD | 91.052% |
Orient EuroPharma Co., Ltd. | 4.59 Billion TWD | 89.982% |
Center Laboratories, Inc. | 1.39 Billion TWD | 67.002% |
Orient Pharma Co., Ltd. | 889.91 Million TWD | 48.31% |
InnoPharmax Inc. | 46.07 Million TWD | -898.4% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 606.71 Million TWD | 24.183% |
Excelsior Biopharma Inc. | 771.56 Million TWD | 40.382% |
DV Biomed Co., Ltd. | 1.53 Billion TWD | 70.098% |
Foresee Pharmaceuticals Co., Ltd. | 195.03 Million TWD | -135.848% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 58.421% |
UniPharma Co., Ltd. | 103.22 Million TWD | -345.635% |
Anxo Pharmaceutical Co., Ltd. | 939.94 Million TWD | 51.062% |
Alar Pharmaceuticals Inc. | 469.27 Million TWD | 1.977% |
Winston Medical Supply Co., Ltd. | 709.07 Million TWD | 35.128% |
Mercury Biopharmaceutical Corporation | 1.03 Million TWD | -44429.816% |
Bioray Biotech Co., Ltd | 191.83 Million TWD | -139.792% |
TSH Biopharm Corporation Limited | 810.91 Million TWD | 43.275% |